Subdural Hematoma Clinical Trial
Official title:
Evaluation of One Burr Hole Evacuation for Subdural Hematoma
To evaluate the outcome of one burrhole evacuation for subdural hematoma and it has the same result of traditional two burrhole
Status | Not yet recruiting |
Enrollment | 35 |
Est. completion date | October 1, 2024 |
Est. primary completion date | July 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with subdural hematoma either unilateral or bilateral - fit for surgery - Chronic SDH - Subacute SDH - Age: patients older than 18 years old - SEX: Both sex Exclusion Criteria: - Patients unfit for surgery - Acute SDH - subdural hyroma - subdural empyema - patient treated conservatively |
Country | Name | City | State |
---|---|---|---|
Egypt | Mohammed lotfi abdelkareem | Assiut | |
Egypt | Mohammed lotfi abdelkareem | Minya | Malawi |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ClinicalEvaluation of evacuation for subdural hematoma by one burrhole | glasgo coma scale,
neurological deficit, clinical symptoms (seizures) . |
72 hours post operative | |
Secondary | Radiological evaluation for outcome | Nearly gross total evacuation according to confirmation by postoperative CT brain | 72 hours post operative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04402632 -
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
|
N/A | |
Completed |
NCT03496545 -
Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury
|
Phase 1/Phase 2 | |
Terminated |
NCT05472766 -
Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma
|
N/A | |
Not yet recruiting |
NCT06052124 -
Augmented Reality for Subdural Drain Placement
|
N/A | |
Completed |
NCT02368366 -
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
|
N/A | |
Terminated |
NCT01463878 -
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
|
Phase 4 | |
Completed |
NCT02618382 -
A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
|
Phase 4 | |
Recruiting |
NCT04923984 -
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
|
N/A | |
Completed |
NCT03153150 -
Start or STop Anticoagulants Randomised Trial (SoSTART)
|
Phase 3 | |
Completed |
NCT04270955 -
Dartmouth Middle Meningeal Embolization Trial (DaMMET)
|
N/A | |
Recruiting |
NCT06067750 -
Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
|
||
Not yet recruiting |
NCT05713630 -
The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma
|
Phase 3 | |
Withdrawn |
NCT01605357 -
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04500795 -
Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma
|
N/A | |
Recruiting |
NCT04170582 -
Patient Registry for Patients With Chronic Subdural Hematoma
|
||
Recruiting |
NCT05649904 -
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
|
N/A | |
Recruiting |
NCT04211233 -
Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE)
|
N/A |